Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Retained Earnings (2016 - 2025)

iBio (IBIO) has disclosed Retained Earnings for 15 consecutive years, with -$346.9 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 7.68% to -$346.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$346.9 million through Dec 2025, down 7.68% year-over-year, with the annual reading at -$332.2 million for FY2025, 5.86% down from the prior year.
  • Retained Earnings for Q4 2025 was -$346.9 million at iBio, down from -$15000.0 in the prior quarter.
  • The five-year high for Retained Earnings was -$15000.0 in Q3 2025, with the low at -$346.9 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$191.9 million, with a median of -$285.9 million recorded in 2023.
  • The sharpest move saw Retained Earnings crashed 366854.72% in 2021, then soared 100.0% in 2025.
  • Over 5 years, Retained Earnings stood at -$194.5 million in 2021, then skyrocketed by 99.91% to -$167000.0 in 2022, then tumbled by 181275.45% to -$302.9 million in 2023, then dropped by 6.37% to -$322.2 million in 2024, then decreased by 7.68% to -$346.9 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$346.9 million, -$15000.0, and -$332.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.